Tech Company Financing Transactions

Predix Pharmaceuticals Holdings Funding Round

Boston Millennia Partners, Forward Ventures and Presidio Partners participated in a $43 million Series C funding round for Predix Pharmaceuticals Holdings. The financing was recorded on 1/25/2005.

Transaction Overview

Company Name
Predix Pharmaceuticals Holdings
Announced On
1/25/2005
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series C
Investors

Boston Millennia Partners (Lead Investor) (Patrick Fortune)

Forward Ventures (Lead Investor) (Joel Martin)

Presidio Partners (Lead Investor) (David Collier)

OrbiMed

Rally Ventures

Proceeds Purpose
The funds raised in this round of financing will allow us to continue the clinical development of our lead compounds and focus on additional discovery and pre-clinical development efforts.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4 Maguire Road
Lexington, MA 02421
USA
Phone
(781) 372-3260
Website
www.predixpharm.com
Email Address
Not Recorded
Overview
Predix Pharmaceuticals is a privately held drug development company integrating computational and medicinal chemistry to rapidly and efficiently create new drugs targeted to GPCRs and ion channels.
Profile
Predix Pharmaceuticals Holdings LinkedIn Company Profile
Social Media
Predix Pharmaceuticals Holdings Company Twitter Account
Company News
Predix Pharmaceuticals Holdings News
Facebook
Predix Pharmaceuticals Holdings on Facebook
YouTube
Predix Pharmaceuticals Holdings on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Kauffman
  Michael Kauffman LinkedIn Profile  Michael Kauffman Twitter Account  Michael Kauffman News  Michael Kauffman on Facebook
Chief Financial Officer
Kim Drapkin
  Kim Drapkin LinkedIn Profile  Kim Drapkin Twitter Account  Kim Drapkin News  Kim Drapkin on Facebook
President
Andrew Uprichard
  Andrew Uprichard LinkedIn Profile  Andrew Uprichard Twitter Account  Andrew Uprichard News  Andrew Uprichard on Facebook
Vice President
Sheila DeWitt
  Sheila DeWitt LinkedIn Profile  Sheila DeWitt Twitter Account  Sheila DeWitt News  Sheila DeWitt on Facebook
Vice President
Simon Jones
  Simon Jones LinkedIn Profile  Simon Jones Twitter Account  Simon Jones News  Simon Jones on Facebook
Vice President
Yael Marantz
  Yael Marantz LinkedIn Profile  Yael Marantz Twitter Account  Yael Marantz News  Yael Marantz on Facebook
Vice President
Sharon Shacham
  Sharon Shacham LinkedIn Profile  Sharon Shacham Twitter Account  Sharon Shacham News  Sharon Shacham on Facebook
VP - Human Resources
Brenda Sousa
  Brenda Sousa LinkedIn Profile  Brenda Sousa Twitter Account  Brenda Sousa News  Brenda Sousa on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/25/2005: Melior Discovery venture capital transaction
Next: 1/25/2005: Incipient venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.